Regeneron Pharmaceuticals, Inc. saw a notable boost in its financial performance this quarter. The Public Sector Pension ...

JPMorgan (NYSE: JPM) told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its “top pick” among U.S.

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

Cary Street Partners Financial LLC dramatically reduced its stake in Regeneron Pharmaceuticals. The firm now holds a mere 255 ...

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

“Overall, MFN remains an overhang for the drug group and something that is unlikely to completely go away in the near term,” JP Morgan analyst Chris Schott ... paying their fair share of innovation,” ...

Regeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD due to inspection findings at a Novo Nordisk-owned manufacturing site, ...

The Regeneron litigation highlights that donations routed through independent entities are not immune from challenge, especially if the government believes they are effectively covering a patient’s co ...

JPMorgan Considers Bitcoin‑Secured Lending JPMorgan is considering offering loans backed by clients’ Bitcoin and crypto assets—a first for the bank and a notable shift in stance from CEO Jamie Dimon.

JPMorgan has temporarily halted plans to re-onboard the cryptocurrency exchange Gemini, following a very public clash over access to consumer banking data. The move comes just days after Gemini co ...

Tyler Winklevoss says JPMorgan blocked Gemini’s onboarding after his public criticism of the bank’s fintech data fees, calling the move anti-competitive.

Tyler Winklevoss, co-founder of Gemini, said that JPMorgan Chase allegedly halted its onboarding process for Gemini after he publicly criticized the bank's new fee structure for fintech companies ...